Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 12Rectal Neoplasms 9Glioblastoma 9Esophageal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Stomach Neoplasms 7Pancreatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Colorectal Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Neoplasms 4Fallopian Tube Neoplasms 4Colonic Neoplasms 3Brain Neoplasms 3Adenocarcinoma of Lung 3Urinary Bladder Neoplasms 2Osteosarcoma 2Melanoma 2Glioma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma Of Esophagus 2Xerostomia 1Wilms Tumor 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Erlotinib Hydrochloride 2dehydroftorafur 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Gemcitabine 1Fluorouracil 1Drug Therapy 1Congresses as Topic 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pancreatic Intraductal Neoplasms × Surgical Procedures, Operative × Clear all
NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 8 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡